Protocol for N-glycoproteomic enrichment of cancer cell-surface proteins in patient-derived xenografts
Cell surface proteins are valuable drug targets and biomarkers, yet are often obscured in traditional mass spectrometry-based proteomics datasets. Leveraging the high prevalence of N -glycosylation on extracellular proteins, we present a protocol for N -glycoproteomic profiling of patient-derived xenografts to enable in vivo characterization of cancer cell-derived surface proteomes. We describe steps for lysis, chemical enrichment, enzymatic modification, and tumor-stroma deconvolution analysis. We also provide a scalable strategy to improve the detection and prioritization of surface proteins in cancers. For complete details on the use and execution of this protocol, please refer to Govindarajan et al. 1
Authors
- Meinusha Govindarajan
- Matthew Waas (ORCID: https://orcid.org/0000-0003-4537-1502)
- Thomas Kislinger (ORCID: https://orcid.org/0000-0003-3525-5540)
- Konrad Celejewski
Institutions
- University Health Network (CA)
- University of Toronto (CA)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- STAR Protocols
- Published
- 2026-08-26
- DOI
- https://doi.org/10.1016/j.xpro.2026.104799
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canadian Cancer Society
- Canadian Institutes of Health Research